Wednesday, July 15, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Europe facing 500,000 more Covid deaths by February, WHO warns

Europe is facing a potentially devastating winter that could see half a million people die with Covid-19, the World Health Organization (WHO) warned, as it sounded the alarm over a surge in cases and bemoaned stuttering vaccination rollouts on parts of the continent.

Much of Europe is battling spikes in infections, with Germany on Thursday reporting its highest number of daily new cases since the pandemic began. And in a dire new warning, WHO regional director Hans Kluge said the pace of transmission across the region was of “grave concern.” “We are, once again, at the epicenter,” Kluge said in a statement.

Source: CNN

https://www.cnn.com/2021/11/04/europe/europe-covid-winter-who-projection-intl/index.html

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!